Aspirin
Aspirin is a pharmaceutical drug with 524 clinical trials. Currently 61 active trials ongoing. Historical success rate of 87.0%.
Success Metrics
Based on 281 completed trials
Phase Distribution
Phase Distribution
67
Early Stage
96
Mid Stage
271
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.4%
281 of 341 finished
17.6%
60 ended early
61
trials recruiting
524
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Thromboxane Function in Women With Endometriosis
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease
Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization
Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
Clinical Trials (524)
Thromboxane Function in Women With Endometriosis
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease
Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization
Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
A Pilot Study to Investigate Platelet Reactivity in Patients With Elevated Lipoprotein(a) and Its Response to Antiplatelet Therapy
Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks
Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime)
Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprosthetic Heart Valve Replacement
ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
Aspirin Monotherapy Versus Sequential Warfarin-Aspirin Therapy After TAVR in Patients With Pure Aortic Regurgitation
Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia
Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent
Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension
Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 524